Stellantis has appointed Antonio Filosa, a 25-year company stalwart, as its new CEO amid an intensified turnaround drive sparked by President Donald Trump's unexpected tariff declaration.
Filosa, presently the COO for Stellantis in the Americas, is set to assume the chief executive role on 23 June after receiving unanimous support from the board, as reported by .
He will be taking over from Carlos Tavares, who was ousted last December following a string of profit warnings triggered by plummeting sales.
READ MORE: {}
The automotive conglomerate, which owns marques such as Vauxhall, Fiat, and Jeep, disclosed plans last year to shut down its significant van production facility in Luton, jeopardising approximately 1,100 jobs.
The company now also grapples with the volatility of Trump's trade policies, which have been unsettling the global car industry of late.
Additionally, the rise of Chinese carmakers in Europe, introducing a wave of affordable electric vehicles, is set to increase competition.
Stellantis hands veteran top job
Filosa, the incoming leader, has previously spearheaded the launch of Jeep in Brazil and the establishment of the Pernambuco plant, a major automotive hub in South America.
"Antonio's deep understanding of our company, including its people who he views as our core strength, and of our industry equip him perfectly for the role of CEO in this next and crucial phase of Stellantis' development," remarked John Elkann, Stellantis' Executive Chairman, who oversaw the selection process.
Most Read
"It is my great honour to be named the CEO of this fantastic company," Filosa expressed in a statement.
"I am grateful to our chairman, John Elkann, and to the members of our board for their leadership, particularly in these recent months, and for the confidence they have placed in me to lead our business during this pivotal time for our industry.
"We have the world's best and most iconic brands in automotive history and an over 100-year heritage of innovation. That legacy... will continue to be key to our success."